Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials
Clinical Psychopharmacology and Neuroscience November 30, 2023 Sunghwan Kim, Won-Seok Choi, Hyun Kook Lim et al. 16 citations
Previous studies suggested effectiveness of psilocybin in the field of mental health. FDA designated psilocybin as a "breakthrough therapy" for the treatment of treatment-resistant depression (TRD) in 2018. This paper provided a review of psilocybin's potential role in treatment of depression by focusing on published clinical trials. Studies showed that psilocybin, an agonist on 5-HT2A...